Group Session 8: Long-Acting Injectables

Part 1: Accelerating Implementation of Multi-Level Strategies to Advance Long-Acting Injectables (ALAI) for People with Lower Incomes

Advance Long-Acting Injectables (ALAI) UP aims to counteract the pattern of new HIV biomedical interventions exacerbating health disparities by supporting clinical programs in building injectable treatment programs that center equity from the beginning, rather than correcting for unintentionally generated health disparities after the fact. 

Learning Objectives

• Describe how the process of developing written protocols that intentionally address equity considerations can mitigate against the risk that new biomedical interventions exacerbate inequities in health outcomes.
• Evaluate whether strategies presented to engage patients as active participants in their own care would be feasible to implement in their own settings.
• Consider feasibility of adding fields specific to injectable treatment into an agency’s electronic medical records in order to monitor the impact that injectable treatment has on agency-level outcomes.

Part 2: Specifying Implementation Strategies to Accelerate Equitable Implementation of Long-Acting Injectable Antiretroviral Therapy

Real-world examples of implementation strategies agencies use to build and scale injectable treatment programs. Participants will be guided to articulate one barrier they face, identify strategies to pilot, and consider measures to evaluate the extent to which the strategy moves their program forward.

Learning Objectives

• Learn strategies clinical sites have used to expand their capacity to implement LAI ART with a focus on equity.
• Apply an implementation science tool to identify strategies to overcome a specific barrier your agency faces in building or scaling their injectable treatment program.
• Consider how to measure the implementation strategy to evaluate whether it is effective in overcoming the barrier.